数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Casey Hoyt 男 Chief Executive Officer and Director 43 262.63万美元 329.58 2021-04-30
Randy Dobbs 男 Chairman 70 27.66万美元 12.55 2021-04-30
William Frazier 男 Chief Medical Officer and Director 62 15.70万美元 10.95 2021-04-30
Bruce Greenstein 男 Director 52 22.96万美元 未持股 2021-04-30
Nitin Kaushal 男 Director 55 25.40万美元 14.26 2021-04-30
Timothy Smokoff 男 Director 56 24.90万美元 9.55 2021-04-30
Sabrina Heltz 女 Director 56 25.16万美元 6.75 2021-04-30
W. Todd Zehnder 男 Chief Operating Officer and Director 45 405.11万美元 107.70 2021-04-30

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Casey Hoyt 男 Chief Executive Officer and Director 43 262.63万美元 329.58 2021-04-30
William Frazier 男 Chief Medical Officer and Director 62 15.70万美元 10.95 2021-04-30
Michael Moore 男 President 43 201.92万美元 229.40 2021-04-30
Trae Fitzgerald 男 Chief Financial Officer 33 91.48万美元 33.24 2021-04-30
Jerome Cambre 男 Vice President of Sales 50 65.61万美元 未持股 2021-04-30
Patrick Eagan 男 General Counsel 42 未披露 未持股 2021-04-30
W. Todd Zehnder 男 Chief Operating Officer and Director 45 405.11万美元 107.70 2021-04-30

董事简历

中英对照 |  中文 |  英文
Casey Hoyt

Casey Hoyt是VieMed的现任首席执行官,他自VieMed于2017年12月从PHM分拆出来以来一直担任该职位。Hoyt先生于2006年联合创立了Sleepco子公司,目标是成为美国领先的呼吸道疾病管理公司。在将Sleepco子公司出售给PHM之后,Hoyt先生成为PHM的首席执行官,直到2017年12月。他的目标一直是通过卓越的临床、教育和技术使患者过上更好的生活。Hoyt先生还成功地管理了其他几项业务,最近的是一家全球性组织,提供全面的贸易展示和营销服务。Hoyt先生在路易斯安那大学拉斐特分校(University of Louisiana at Lafayette)获得通识研究理学学士学位。


Casey Hoyt is the current Chief Executive Officer of the Corporation, a position he has held since its spin out from Protech Home Medical Corp. “PHM” in December 2017. Mr. Hoyt co-founded our subsidiaries Sleep Management, L.L.C. and Home Sleep Delivered, L.L.C. (collectively, the “Sleepco Subsidiaries”) in 2006 with the objective of becoming the leading respiratory disease management company in the United States. After selling the Sleepco Subsidiaries to PHM, Mr. Hoyt became the Chief Executive Officer of PHM until December 2017. His goal has been to enable patients to live better lives through clinical excellence, education and technology. Mr. Hoyt has also successfully managed several other businesses, most recently a worldwide organization offering a comprehensive line of tradeshow display and marketing services. Mr. Hoyt received his Bachelor of Science in General Studies from the University of Louisiana at Lafayette.
Casey Hoyt是VieMed的现任首席执行官,他自VieMed于2017年12月从PHM分拆出来以来一直担任该职位。Hoyt先生于2006年联合创立了Sleepco子公司,目标是成为美国领先的呼吸道疾病管理公司。在将Sleepco子公司出售给PHM之后,Hoyt先生成为PHM的首席执行官,直到2017年12月。他的目标一直是通过卓越的临床、教育和技术使患者过上更好的生活。Hoyt先生还成功地管理了其他几项业务,最近的是一家全球性组织,提供全面的贸易展示和营销服务。Hoyt先生在路易斯安那大学拉斐特分校(University of Louisiana at Lafayette)获得通识研究理学学士学位。
Casey Hoyt is the current Chief Executive Officer of the Corporation, a position he has held since its spin out from Protech Home Medical Corp. “PHM” in December 2017. Mr. Hoyt co-founded our subsidiaries Sleep Management, L.L.C. and Home Sleep Delivered, L.L.C. (collectively, the “Sleepco Subsidiaries”) in 2006 with the objective of becoming the leading respiratory disease management company in the United States. After selling the Sleepco Subsidiaries to PHM, Mr. Hoyt became the Chief Executive Officer of PHM until December 2017. His goal has been to enable patients to live better lives through clinical excellence, education and technology. Mr. Hoyt has also successfully managed several other businesses, most recently a worldwide organization offering a comprehensive line of tradeshow display and marketing services. Mr. Hoyt received his Bachelor of Science in General Studies from the University of Louisiana at Lafayette.
Randy Dobbs

自2017年12月Viemed从PHM分拆出来以来,Randy Dobbs一直担任董事会主席。Dobbs先生是一名业务运营/领导顾问和激励演讲人,自2010年以来一直担任该职位。2012年4月至2015年1月,Dobbs先生担任Matrix Medical Network的首席执行官,该公司是Welsh,Carson,Anderson&Stowe“;WCAS”;的投资组合公司,是32个州Medicare Advantage成员的家庭健康评估提供商。此前,他曾担任WCAS公司的高级运营执行官,在那里他曾负责投资组合公司的运营监督、业务收购和股权机会开发。从2005年2月到2008年10月,他曾担任US Investigation Services公司及其子公司(USIS)的首席执行官,为企业和联邦政府机构提供商业情报和风险管理解决方案、安全和相关服务以及专家人员配置解决方案。Dobbs从2003年4月到2005年2月担任Phillips Medical Systems North America总裁和首席执行官,在整个北美和拉丁美洲提供诊断成像设备和服务。2003年4月之前,Dobbs先生在通用电气公司工作了27年,担任过多个高级职位,包括通用电气资本IT解决方案公司(GE Capital IT Solutions)的总裁兼首席执行官,这是一家市值数十亿美元的企业。Dobbs先生于2010年至2018年担任MTGE InvestmentCorp.(Nasdaq:MTGE)董事会成员,并担任多家私人控股公司的董事会成员。Dobbs先生在阿肯色州立大学(Arkansas State University)获得工程学理学学士学位。


Randy Dobbs has served as the chairman of the Board since the Corporation's spin out from PHM in December 2017. In November 2020 Mr. Dobbs joined American Vision Partners, a physician practice management company affiliated with numerous vision care facilities across the Southwestern United States, in the role of CEO. Mr. Dobbs is also a noted business operating/leadership consultant and motivational speaker and has served in that capacity since 2010. From April 2012 to January 2015 Mr. Dobbs served as the Chief Executive Officer for Matrix Medical Network, a portfolio company of Welsh, Carson, Anderson & Stowe “WCAS” and a provider of home health assessments for Medicare Advantage members across 32 states. Prior to that role, he was a Senior Operating Executive at WCAS, where he was responsible for portfolio company operational oversight, business acquisitions and equity opportunity development. From February 2005 to October 2008 he was Chief Executive Officer of US Investigation Services and its subsidiaries who provided business intelligence and risk management solutions, security and related services and expert staffing solutions for businesses and federal government agencies. From April 2003 to February 2005 Mr. Dobbs was President and CEO of Phillips Medical Systems North America, providing diagnostic imaging equipment and services throughout all of North America and Latin America. Prior to April 2003 Mr. Dobbs spent 27 years with General Electric Company where he held various senior level positions including President and CEO of GE Capital IT Solutions, a multi-billion dollar enterprise. Mr. Dobbs served on the board of directors of MTGE Investment Corp. (NASDAQ:MTGE) from 2010 to 2018 and serves on the boards of directors of several privately held companies. Mr. Dobbs earned a Bachelor of Science in Education from Arkansas State University.
自2017年12月Viemed从PHM分拆出来以来,Randy Dobbs一直担任董事会主席。Dobbs先生是一名业务运营/领导顾问和激励演讲人,自2010年以来一直担任该职位。2012年4月至2015年1月,Dobbs先生担任Matrix Medical Network的首席执行官,该公司是Welsh,Carson,Anderson&Stowe“;WCAS”;的投资组合公司,是32个州Medicare Advantage成员的家庭健康评估提供商。此前,他曾担任WCAS公司的高级运营执行官,在那里他曾负责投资组合公司的运营监督、业务收购和股权机会开发。从2005年2月到2008年10月,他曾担任US Investigation Services公司及其子公司(USIS)的首席执行官,为企业和联邦政府机构提供商业情报和风险管理解决方案、安全和相关服务以及专家人员配置解决方案。Dobbs从2003年4月到2005年2月担任Phillips Medical Systems North America总裁和首席执行官,在整个北美和拉丁美洲提供诊断成像设备和服务。2003年4月之前,Dobbs先生在通用电气公司工作了27年,担任过多个高级职位,包括通用电气资本IT解决方案公司(GE Capital IT Solutions)的总裁兼首席执行官,这是一家市值数十亿美元的企业。Dobbs先生于2010年至2018年担任MTGE InvestmentCorp.(Nasdaq:MTGE)董事会成员,并担任多家私人控股公司的董事会成员。Dobbs先生在阿肯色州立大学(Arkansas State University)获得工程学理学学士学位。
Randy Dobbs has served as the chairman of the Board since the Corporation's spin out from PHM in December 2017. In November 2020 Mr. Dobbs joined American Vision Partners, a physician practice management company affiliated with numerous vision care facilities across the Southwestern United States, in the role of CEO. Mr. Dobbs is also a noted business operating/leadership consultant and motivational speaker and has served in that capacity since 2010. From April 2012 to January 2015 Mr. Dobbs served as the Chief Executive Officer for Matrix Medical Network, a portfolio company of Welsh, Carson, Anderson & Stowe “WCAS” and a provider of home health assessments for Medicare Advantage members across 32 states. Prior to that role, he was a Senior Operating Executive at WCAS, where he was responsible for portfolio company operational oversight, business acquisitions and equity opportunity development. From February 2005 to October 2008 he was Chief Executive Officer of US Investigation Services and its subsidiaries who provided business intelligence and risk management solutions, security and related services and expert staffing solutions for businesses and federal government agencies. From April 2003 to February 2005 Mr. Dobbs was President and CEO of Phillips Medical Systems North America, providing diagnostic imaging equipment and services throughout all of North America and Latin America. Prior to April 2003 Mr. Dobbs spent 27 years with General Electric Company where he held various senior level positions including President and CEO of GE Capital IT Solutions, a multi-billion dollar enterprise. Mr. Dobbs served on the board of directors of MTGE Investment Corp. (NASDAQ:MTGE) from 2010 to 2018 and serves on the boards of directors of several privately held companies. Mr. Dobbs earned a Bachelor of Science in Education from Arkansas State University.
William Frazier

William Frazier自2017年12月起担任VieMed的首席医疗官和董事。此前,Frazier博士于2015年10月至2017年12月担任PHM的首席医疗官。在此之前,Frazier博士自2015年10月起担任Sleepco子公司的首席医疗官。在Sleepco子公司之前,Frazier博士作为一名全职执业肺科医生工作了超过25年,他目前继续在兼职的基础上为患者看病。Frazier在他的职业生涯中担任过许多不同的领导职务,包括Stits担任医疗幕僚长和两个大型医疗实践的董事会成员,并担任地区卫生系统的董事。Frazier博士目前在内科、肺科、重症监护医学和睡眠障碍医学方面获得ABIM董事会认证。Frazier博士在范德堡大学(Vanderbilt University)获得理学哲学学士学位,在密西西比大学(University of Mississippi)获得医学博士学位,并在弗吉尼亚大学(University of Virginia)获得博士后培训。


William Frazier has served as Chief Medical Officer and as a director of the Corporation since December 2017. Previously, Dr. Frazier served as Chief Medical Officer of PHM from October 2015 to December 2017. Prior to that, Dr. Frazier was the Chief Medical Officer for the Sleepco Subsidiaries since October 2015. Prior to the Sleepco Subsidiaries, Dr. Frazier worked for more than 30 years as a full time practicing pulmonologist. Dr. Frazier has experience conducting clinical research projects, including trials evaluating new treatment options for COPD, and he has published scientific papers on the topic of COPD and home ventilation. Dr. Frazier has served in many different leadership roles during his career including stints as Chief of the Medical Staff and on the board of directors of two large medical practices and as a Director of a regional health system. Dr. Frazier is currently ABIM Board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine and Sleep Disorders Medicine. Dr. Frazier earned his Bachelor of Science Philosophy from Vanderbilt University, his M.D. from the University of Mississippi and post-doctoral training at the University of Virginia.
William Frazier自2017年12月起担任VieMed的首席医疗官和董事。此前,Frazier博士于2015年10月至2017年12月担任PHM的首席医疗官。在此之前,Frazier博士自2015年10月起担任Sleepco子公司的首席医疗官。在Sleepco子公司之前,Frazier博士作为一名全职执业肺科医生工作了超过25年,他目前继续在兼职的基础上为患者看病。Frazier在他的职业生涯中担任过许多不同的领导职务,包括Stits担任医疗幕僚长和两个大型医疗实践的董事会成员,并担任地区卫生系统的董事。Frazier博士目前在内科、肺科、重症监护医学和睡眠障碍医学方面获得ABIM董事会认证。Frazier博士在范德堡大学(Vanderbilt University)获得理学哲学学士学位,在密西西比大学(University of Mississippi)获得医学博士学位,并在弗吉尼亚大学(University of Virginia)获得博士后培训。
William Frazier has served as Chief Medical Officer and as a director of the Corporation since December 2017. Previously, Dr. Frazier served as Chief Medical Officer of PHM from October 2015 to December 2017. Prior to that, Dr. Frazier was the Chief Medical Officer for the Sleepco Subsidiaries since October 2015. Prior to the Sleepco Subsidiaries, Dr. Frazier worked for more than 30 years as a full time practicing pulmonologist. Dr. Frazier has experience conducting clinical research projects, including trials evaluating new treatment options for COPD, and he has published scientific papers on the topic of COPD and home ventilation. Dr. Frazier has served in many different leadership roles during his career including stints as Chief of the Medical Staff and on the board of directors of two large medical practices and as a Director of a regional health system. Dr. Frazier is currently ABIM Board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine and Sleep Disorders Medicine. Dr. Frazier earned his Bachelor of Science Philosophy from Vanderbilt University, his M.D. from the University of Mississippi and post-doctoral training at the University of Virginia.
Bruce Greenstein

Bruce Greenstein自2018年7月起担任董事。Greenstein先生一直担任LHCGroup,Inc.的执行Vice President兼首席战略与创新官纳斯达克股票代码:LHCG,自2018年起领导公司基于价值的承包,ACO管理公司以及替代付款和交付模式战略。他还负责监督LHC集团的技术和创新业务部门的运营,以及LHC集团的梦百合愿景计划。在加入LHC Group之前,Greenstein先生于2017年5月至2018年6月担任华盛顿特区美国卫生与公共服务部(HHS)的首席技术官。他在政府和私营部门都有广泛的梦百合行业背景,曾担任总部设在纽约的Quartet Health公司的西部总裁、Blend Health Insights公司的首席执行官,以及Microsoft公司的全球卫生董事总经理。Greenstein先生曾是路易斯安那州的内阁成员,担任卫生与医院部部长。他之前还在Medicare&Medicaid Services中心运行Medicaid管理的护理和豁免和示范。


Bruce Greenstein joined the company in June 2018. As Executive Vice President and Chief Strategy and Innovation Officer, he leads the company's value-based contracting, ACO management company, and alternative payment and delivery model strategies. Mr. Greenstein previously served as Chief Technology Officer CTO for the U.S. Department of Health and Human Services HHS in Washington, D.C. from 2017 to 2018. He has an extensive healthcare industry background in both government and the private sector, having served as President-West for New York-based Quartet Health from 2016 to 2017 CEO of Blend Health Insights from 2013 to 2016 and as managing director of Worldwide Health for Microsoft from 2006 to 2010. Mr. Greenstein was a cabinet member in Louisiana, serving as secretary of the Department of Health and Hospitals from 2010 to 2013. He also previously ran Medicaid-managed care and waivers and demonstrations at the Centers for Medicare & Medicaid Services CMS from 2003 to 2005.
Bruce Greenstein自2018年7月起担任董事。Greenstein先生一直担任LHCGroup,Inc.的执行Vice President兼首席战略与创新官纳斯达克股票代码:LHCG,自2018年起领导公司基于价值的承包,ACO管理公司以及替代付款和交付模式战略。他还负责监督LHC集团的技术和创新业务部门的运营,以及LHC集团的梦百合愿景计划。在加入LHC Group之前,Greenstein先生于2017年5月至2018年6月担任华盛顿特区美国卫生与公共服务部(HHS)的首席技术官。他在政府和私营部门都有广泛的梦百合行业背景,曾担任总部设在纽约的Quartet Health公司的西部总裁、Blend Health Insights公司的首席执行官,以及Microsoft公司的全球卫生董事总经理。Greenstein先生曾是路易斯安那州的内阁成员,担任卫生与医院部部长。他之前还在Medicare&Medicaid Services中心运行Medicaid管理的护理和豁免和示范。
Bruce Greenstein joined the company in June 2018. As Executive Vice President and Chief Strategy and Innovation Officer, he leads the company's value-based contracting, ACO management company, and alternative payment and delivery model strategies. Mr. Greenstein previously served as Chief Technology Officer CTO for the U.S. Department of Health and Human Services HHS in Washington, D.C. from 2017 to 2018. He has an extensive healthcare industry background in both government and the private sector, having served as President-West for New York-based Quartet Health from 2016 to 2017 CEO of Blend Health Insights from 2013 to 2016 and as managing director of Worldwide Health for Microsoft from 2006 to 2010. Mr. Greenstein was a cabinet member in Louisiana, serving as secretary of the Department of Health and Hospitals from 2010 to 2013. He also previously ran Medicaid-managed care and waivers and demonstrations at the Centers for Medicare & Medicaid Services CMS from 2003 to 2005.
Nitin Kaushal

Nitin Kaushal自2024年10月起担任Synergy CHC Corp.董事会成员。自2020年3月起,Kaushal先生担任Anik Capital Corp.总裁。他从普华永道会计师事务所(加拿大)退休,并于2012年4月至2020年2月担任公司融资业务的董事总经理。他在金融服务行业拥有超过35年的经验,曾在投资银行、风险投资和咨询公司担任高级职务,包括Desjardins Securities Inc.、Orion Securities Inc.、Vengate Capital、HSBC Securities Inc.和Gordon Capital,并在MDS Capital Corp的风险投资行业担任高级职务。Kaushal先生在VieMed Healthcare,Inc.和Everyday People Financial Inc.的董事会任职。Kaushal先生在多伦多大学获得化学理学学士学位,是加拿大的特许会计师。Kaushal先生作为各董事会成员和特许会计师的经验为董事会提供了关于财务报告、治理和管理问题的额外视角,并得出结论认为,他应担任Synergy CHC Corp.董事会成员。


Nitin Kaushal has served on Synergy Chc Corp.'s Board of Directors since October 2024. Since March 2020, Mr. Kaushal has served as President of Anik Capital Corp. He retired from PricewaterhouseCoopers LLP (Canada), where he was a Managing Director in the Corporate Finance Practice from April 2012 until February 2020. He has over thirty five years of experience in the financial services industry and has held senior roles in investment banking, venture capital and consulting firms including Desjardins Securities Inc., Orion Securities Inc., Vengate Capital, HSBC Securities Inc. and Gordon Capital and in the venture capital industry with MDS Capital Corp. Mr. Kaushal serves on the board of VieMed Healthcare, Inc. and Everyday People Financial Inc. Mr. Kaushal earned his Bachelor of Science in Chemistry from the University of Toronto and is a Chartered Accountant in Canada. Mr. Kaushal's experience as a member of various boards of directors and as a Chartered Accountant provides the Board with additional perspective on financial reporting, governance and management issues and led to the conclusion that he should serve as a member of Synergy Chc Corp.'s Board of Directors.
Nitin Kaushal自2024年10月起担任Synergy CHC Corp.董事会成员。自2020年3月起,Kaushal先生担任Anik Capital Corp.总裁。他从普华永道会计师事务所(加拿大)退休,并于2012年4月至2020年2月担任公司融资业务的董事总经理。他在金融服务行业拥有超过35年的经验,曾在投资银行、风险投资和咨询公司担任高级职务,包括Desjardins Securities Inc.、Orion Securities Inc.、Vengate Capital、HSBC Securities Inc.和Gordon Capital,并在MDS Capital Corp的风险投资行业担任高级职务。Kaushal先生在VieMed Healthcare,Inc.和Everyday People Financial Inc.的董事会任职。Kaushal先生在多伦多大学获得化学理学学士学位,是加拿大的特许会计师。Kaushal先生作为各董事会成员和特许会计师的经验为董事会提供了关于财务报告、治理和管理问题的额外视角,并得出结论认为,他应担任Synergy CHC Corp.董事会成员。
Nitin Kaushal has served on Synergy Chc Corp.'s Board of Directors since October 2024. Since March 2020, Mr. Kaushal has served as President of Anik Capital Corp. He retired from PricewaterhouseCoopers LLP (Canada), where he was a Managing Director in the Corporate Finance Practice from April 2012 until February 2020. He has over thirty five years of experience in the financial services industry and has held senior roles in investment banking, venture capital and consulting firms including Desjardins Securities Inc., Orion Securities Inc., Vengate Capital, HSBC Securities Inc. and Gordon Capital and in the venture capital industry with MDS Capital Corp. Mr. Kaushal serves on the board of VieMed Healthcare, Inc. and Everyday People Financial Inc. Mr. Kaushal earned his Bachelor of Science in Chemistry from the University of Toronto and is a Chartered Accountant in Canada. Mr. Kaushal's experience as a member of various boards of directors and as a Chartered Accountant provides the Board with additional perspective on financial reporting, governance and management issues and led to the conclusion that he should serve as a member of Synergy Chc Corp.'s Board of Directors.
Timothy Smokoff

Timothy Smokoff自2018年1月起担任董事。Smokoff先生目前是Breathometer,Inc.的首席执行官,自2017年1月起担任该职位。在加入Breathometer之前,Smokoff先生是Nortek,Inc.健康和福利部的高级副总裁Smokoff先生从2011年1月开始担任Numera,Inc.的首席执行官,该公司是一家资深的就地老化解决方案公司,直到2016年7月被Nortek,Inc.收购。在Numera,Inc.之前Smokoff在Microsoft任职13年,担任多个职位,最后6年领导Microsoft全球健康业务。Smokoff先生在华盛顿大学(University of Washington)获得计算机科学文学学士学位。


Timothy Smokoff has served as a director since January 2018, product development and delivery experience to the Corporation. Mr. Smokoff is currently CEO of CareXM, LLC, a position he has held since November 2020. Prior to that, Mr. Smokoff was CEO of Isowalk, LLC, a position he held from January 2019 to November 2020. Mr. Smokoff has also served on the board of Total Triage Holdings, LLC since November of 2019. Prior to Isowalk, Mr Smokoff was CEO of Breathometer, Inc. from January 2017 to January 2019 and Senior Vice President of Health and Wellness of Nortek, Inc. from July 2016 to January 2017. Mr. Smokoff was the Chief Executive Officer of Numera, Inc., a senior in place aging solutions company, from January 2011 until it was purchased by Nortek, Inc. in July of 2016. Prior to Numera,Inc. Mr. Smokoff spent 13 years at Microsoft in various capacities, the last six years leading Microsoft's global health business.Mr. Smokoff earned a Bachelor of Arts in Computer Science from the University of Washington.
Timothy Smokoff自2018年1月起担任董事。Smokoff先生目前是Breathometer,Inc.的首席执行官,自2017年1月起担任该职位。在加入Breathometer之前,Smokoff先生是Nortek,Inc.健康和福利部的高级副总裁Smokoff先生从2011年1月开始担任Numera,Inc.的首席执行官,该公司是一家资深的就地老化解决方案公司,直到2016年7月被Nortek,Inc.收购。在Numera,Inc.之前Smokoff在Microsoft任职13年,担任多个职位,最后6年领导Microsoft全球健康业务。Smokoff先生在华盛顿大学(University of Washington)获得计算机科学文学学士学位。
Timothy Smokoff has served as a director since January 2018, product development and delivery experience to the Corporation. Mr. Smokoff is currently CEO of CareXM, LLC, a position he has held since November 2020. Prior to that, Mr. Smokoff was CEO of Isowalk, LLC, a position he held from January 2019 to November 2020. Mr. Smokoff has also served on the board of Total Triage Holdings, LLC since November of 2019. Prior to Isowalk, Mr Smokoff was CEO of Breathometer, Inc. from January 2017 to January 2019 and Senior Vice President of Health and Wellness of Nortek, Inc. from July 2016 to January 2017. Mr. Smokoff was the Chief Executive Officer of Numera, Inc., a senior in place aging solutions company, from January 2011 until it was purchased by Nortek, Inc. in July of 2016. Prior to Numera,Inc. Mr. Smokoff spent 13 years at Microsoft in various capacities, the last six years leading Microsoft's global health business.Mr. Smokoff earned a Bachelor of Arts in Computer Science from the University of Washington.
Sabrina Heltz

Sabrina Heltz的职业生涯始于路易斯安那州的Blue Cross and Blue Shield“;BCBSLA”;,担任精算师,并获得了精算师协会会员和美国精算师学会会员的资格。在BCBSLA工作期间,她提升了自己的角色和职责,最终担任该计划的高级副总裁/首席精算师长达五年。她的职业生涯随后过渡到管理BCBSLA的其他运营领域,包括其药房福利计划,医疗管理计划和供应商报销领域。她在BCBSLA结束了31年的职业生涯,担任高级副总裁,负责监督该计划的供应商合同和报销计划,领导该计划的数据和分析能力的进步,以实现基于价值的报销计划以及创新的质量和护理改进计划。在BCBSLA的职业生涯结束后,她在Ochsner Health Network担任了4年的首席运营官,最近过渡到执行顾问,协助该网络的战略和运营,以使Medicare和商业健康计划提供的基于价值的合同获得成功。Heltz女士在尼科尔斯州立大学获得数学和计算机科学理学学士学位。


Sabrina Heltz began her career at Blue Cross and Blue Shield of Louisiana “BCBSLA” as an actuary and earned her credentials as an Associate in the Society of Actuaries and a Member of the American Academy of Actuaries. During her time at BCBSLA, she ascended in her role and responsibilities, ultimately serving as SVP/Chief Actuary of the plan for five years. Her career then transitioned to managing other operational areas of BCBSLA, including its pharmacy benefits program, medical management program and provider reimbursement areas. She ended her 31 year career at BCBSLA as SVP overseeing the provider contracting and reimbursement programs for the plan, spearheading the advancement of the plan's data and analytics capabilities to enable value based reimbursement programs and innovative quality and care improvement programs. Following her career at BCBSLA, she served for four years at Ochsner Health Network as Chief Operations Officer and recently transitioned to an executive advisor, assisting the network in its strategy and operations to enable success in value based contracts offered by Medicare and commercial health plans. Ms. Heltz earned a Bachelor of Science in Mathematics and Computer Science from Nicholls State University.
Sabrina Heltz的职业生涯始于路易斯安那州的Blue Cross and Blue Shield“;BCBSLA”;,担任精算师,并获得了精算师协会会员和美国精算师学会会员的资格。在BCBSLA工作期间,她提升了自己的角色和职责,最终担任该计划的高级副总裁/首席精算师长达五年。她的职业生涯随后过渡到管理BCBSLA的其他运营领域,包括其药房福利计划,医疗管理计划和供应商报销领域。她在BCBSLA结束了31年的职业生涯,担任高级副总裁,负责监督该计划的供应商合同和报销计划,领导该计划的数据和分析能力的进步,以实现基于价值的报销计划以及创新的质量和护理改进计划。在BCBSLA的职业生涯结束后,她在Ochsner Health Network担任了4年的首席运营官,最近过渡到执行顾问,协助该网络的战略和运营,以使Medicare和商业健康计划提供的基于价值的合同获得成功。Heltz女士在尼科尔斯州立大学获得数学和计算机科学理学学士学位。
Sabrina Heltz began her career at Blue Cross and Blue Shield of Louisiana “BCBSLA” as an actuary and earned her credentials as an Associate in the Society of Actuaries and a Member of the American Academy of Actuaries. During her time at BCBSLA, she ascended in her role and responsibilities, ultimately serving as SVP/Chief Actuary of the plan for five years. Her career then transitioned to managing other operational areas of BCBSLA, including its pharmacy benefits program, medical management program and provider reimbursement areas. She ended her 31 year career at BCBSLA as SVP overseeing the provider contracting and reimbursement programs for the plan, spearheading the advancement of the plan's data and analytics capabilities to enable value based reimbursement programs and innovative quality and care improvement programs. Following her career at BCBSLA, she served for four years at Ochsner Health Network as Chief Operations Officer and recently transitioned to an executive advisor, assisting the network in its strategy and operations to enable success in value based contracts offered by Medicare and commercial health plans. Ms. Heltz earned a Bachelor of Science in Mathematics and Computer Science from Nicholls State University.
W. Todd Zehnder

W. Todd Zehnder,2009年10月起,他担任我公司首席运营官。2008年3月至2009年10月,他担任我公司执行副总裁、首席财务官和会计长;2001年2月至2004年10月,担任我公司财务长;2003年6月至2005年6月,担任我公司营销经理;2004年10月至2005年6月,担任我公司通信董事;2005年6月至2007年5月,担任公司通信副总裁;2005年6月至2008年3月,担任石油天然气营销副总裁;2007年5月至2008年3月,担任公司发展副总裁。2001年2月加入我公司之前,他在毕马威会计师事务所(KPMG LLP)工作5年,负责石油天然气业,达到经理职位。1996年,他在路易斯安那州立大学(Louisiana State University)获得理学士学位,是美国独立石油协会(Independent Petroleum Association of America)、路易斯安那石油天然气协会(Louisiana Oil & Gas Association)和美国注册会计师协会(American Institute of Certified Public Accountants)的成员。


W. Todd Zehnder has served as the Chief Operating Officer and as a director of the Corporation since December 2017. Previously, Mr. Zehnder served as Vice President - Finance and as Chief Strategy Officer of PHM from December 2015 to December 2017. Prior to joining PHM, Mr. Zehnder worked for PetroQuest Energy Inc., which was then a NYSE listed company, for 15 years in various leadership positions, including as Chief Operating Officer and Chief Financial Officer from 2008 to December 2015. Mr. Zehnder began his career with KPMG LLP where he attained the level of Manager. Mr. Zehnder received his Bachelor of Science degree in Accounting from Louisiana State University and is a Certified Public Accountant.
W. Todd Zehnder,2009年10月起,他担任我公司首席运营官。2008年3月至2009年10月,他担任我公司执行副总裁、首席财务官和会计长;2001年2月至2004年10月,担任我公司财务长;2003年6月至2005年6月,担任我公司营销经理;2004年10月至2005年6月,担任我公司通信董事;2005年6月至2007年5月,担任公司通信副总裁;2005年6月至2008年3月,担任石油天然气营销副总裁;2007年5月至2008年3月,担任公司发展副总裁。2001年2月加入我公司之前,他在毕马威会计师事务所(KPMG LLP)工作5年,负责石油天然气业,达到经理职位。1996年,他在路易斯安那州立大学(Louisiana State University)获得理学士学位,是美国独立石油协会(Independent Petroleum Association of America)、路易斯安那石油天然气协会(Louisiana Oil & Gas Association)和美国注册会计师协会(American Institute of Certified Public Accountants)的成员。
W. Todd Zehnder has served as the Chief Operating Officer and as a director of the Corporation since December 2017. Previously, Mr. Zehnder served as Vice President - Finance and as Chief Strategy Officer of PHM from December 2015 to December 2017. Prior to joining PHM, Mr. Zehnder worked for PetroQuest Energy Inc., which was then a NYSE listed company, for 15 years in various leadership positions, including as Chief Operating Officer and Chief Financial Officer from 2008 to December 2015. Mr. Zehnder began his career with KPMG LLP where he attained the level of Manager. Mr. Zehnder received his Bachelor of Science degree in Accounting from Louisiana State University and is a Certified Public Accountant.

高管简历

中英对照 |  中文 |  英文
Casey Hoyt

Casey Hoyt是VieMed的现任首席执行官,他自VieMed于2017年12月从PHM分拆出来以来一直担任该职位。Hoyt先生于2006年联合创立了Sleepco子公司,目标是成为美国领先的呼吸道疾病管理公司。在将Sleepco子公司出售给PHM之后,Hoyt先生成为PHM的首席执行官,直到2017年12月。他的目标一直是通过卓越的临床、教育和技术使患者过上更好的生活。Hoyt先生还成功地管理了其他几项业务,最近的是一家全球性组织,提供全面的贸易展示和营销服务。Hoyt先生在路易斯安那大学拉斐特分校(University of Louisiana at Lafayette)获得通识研究理学学士学位。


Casey Hoyt is the current Chief Executive Officer of the Corporation, a position he has held since its spin out from Protech Home Medical Corp. “PHM” in December 2017. Mr. Hoyt co-founded our subsidiaries Sleep Management, L.L.C. and Home Sleep Delivered, L.L.C. (collectively, the “Sleepco Subsidiaries”) in 2006 with the objective of becoming the leading respiratory disease management company in the United States. After selling the Sleepco Subsidiaries to PHM, Mr. Hoyt became the Chief Executive Officer of PHM until December 2017. His goal has been to enable patients to live better lives through clinical excellence, education and technology. Mr. Hoyt has also successfully managed several other businesses, most recently a worldwide organization offering a comprehensive line of tradeshow display and marketing services. Mr. Hoyt received his Bachelor of Science in General Studies from the University of Louisiana at Lafayette.
Casey Hoyt是VieMed的现任首席执行官,他自VieMed于2017年12月从PHM分拆出来以来一直担任该职位。Hoyt先生于2006年联合创立了Sleepco子公司,目标是成为美国领先的呼吸道疾病管理公司。在将Sleepco子公司出售给PHM之后,Hoyt先生成为PHM的首席执行官,直到2017年12月。他的目标一直是通过卓越的临床、教育和技术使患者过上更好的生活。Hoyt先生还成功地管理了其他几项业务,最近的是一家全球性组织,提供全面的贸易展示和营销服务。Hoyt先生在路易斯安那大学拉斐特分校(University of Louisiana at Lafayette)获得通识研究理学学士学位。
Casey Hoyt is the current Chief Executive Officer of the Corporation, a position he has held since its spin out from Protech Home Medical Corp. “PHM” in December 2017. Mr. Hoyt co-founded our subsidiaries Sleep Management, L.L.C. and Home Sleep Delivered, L.L.C. (collectively, the “Sleepco Subsidiaries”) in 2006 with the objective of becoming the leading respiratory disease management company in the United States. After selling the Sleepco Subsidiaries to PHM, Mr. Hoyt became the Chief Executive Officer of PHM until December 2017. His goal has been to enable patients to live better lives through clinical excellence, education and technology. Mr. Hoyt has also successfully managed several other businesses, most recently a worldwide organization offering a comprehensive line of tradeshow display and marketing services. Mr. Hoyt received his Bachelor of Science in General Studies from the University of Louisiana at Lafayette.
William Frazier

William Frazier自2017年12月起担任VieMed的首席医疗官和董事。此前,Frazier博士于2015年10月至2017年12月担任PHM的首席医疗官。在此之前,Frazier博士自2015年10月起担任Sleepco子公司的首席医疗官。在Sleepco子公司之前,Frazier博士作为一名全职执业肺科医生工作了超过25年,他目前继续在兼职的基础上为患者看病。Frazier在他的职业生涯中担任过许多不同的领导职务,包括Stits担任医疗幕僚长和两个大型医疗实践的董事会成员,并担任地区卫生系统的董事。Frazier博士目前在内科、肺科、重症监护医学和睡眠障碍医学方面获得ABIM董事会认证。Frazier博士在范德堡大学(Vanderbilt University)获得理学哲学学士学位,在密西西比大学(University of Mississippi)获得医学博士学位,并在弗吉尼亚大学(University of Virginia)获得博士后培训。


William Frazier has served as Chief Medical Officer and as a director of the Corporation since December 2017. Previously, Dr. Frazier served as Chief Medical Officer of PHM from October 2015 to December 2017. Prior to that, Dr. Frazier was the Chief Medical Officer for the Sleepco Subsidiaries since October 2015. Prior to the Sleepco Subsidiaries, Dr. Frazier worked for more than 30 years as a full time practicing pulmonologist. Dr. Frazier has experience conducting clinical research projects, including trials evaluating new treatment options for COPD, and he has published scientific papers on the topic of COPD and home ventilation. Dr. Frazier has served in many different leadership roles during his career including stints as Chief of the Medical Staff and on the board of directors of two large medical practices and as a Director of a regional health system. Dr. Frazier is currently ABIM Board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine and Sleep Disorders Medicine. Dr. Frazier earned his Bachelor of Science Philosophy from Vanderbilt University, his M.D. from the University of Mississippi and post-doctoral training at the University of Virginia.
William Frazier自2017年12月起担任VieMed的首席医疗官和董事。此前,Frazier博士于2015年10月至2017年12月担任PHM的首席医疗官。在此之前,Frazier博士自2015年10月起担任Sleepco子公司的首席医疗官。在Sleepco子公司之前,Frazier博士作为一名全职执业肺科医生工作了超过25年,他目前继续在兼职的基础上为患者看病。Frazier在他的职业生涯中担任过许多不同的领导职务,包括Stits担任医疗幕僚长和两个大型医疗实践的董事会成员,并担任地区卫生系统的董事。Frazier博士目前在内科、肺科、重症监护医学和睡眠障碍医学方面获得ABIM董事会认证。Frazier博士在范德堡大学(Vanderbilt University)获得理学哲学学士学位,在密西西比大学(University of Mississippi)获得医学博士学位,并在弗吉尼亚大学(University of Virginia)获得博士后培训。
William Frazier has served as Chief Medical Officer and as a director of the Corporation since December 2017. Previously, Dr. Frazier served as Chief Medical Officer of PHM from October 2015 to December 2017. Prior to that, Dr. Frazier was the Chief Medical Officer for the Sleepco Subsidiaries since October 2015. Prior to the Sleepco Subsidiaries, Dr. Frazier worked for more than 30 years as a full time practicing pulmonologist. Dr. Frazier has experience conducting clinical research projects, including trials evaluating new treatment options for COPD, and he has published scientific papers on the topic of COPD and home ventilation. Dr. Frazier has served in many different leadership roles during his career including stints as Chief of the Medical Staff and on the board of directors of two large medical practices and as a Director of a regional health system. Dr. Frazier is currently ABIM Board certified in Internal Medicine, Pulmonary Medicine, Critical Care Medicine and Sleep Disorders Medicine. Dr. Frazier earned his Bachelor of Science Philosophy from Vanderbilt University, his M.D. from the University of Mississippi and post-doctoral training at the University of Virginia.
Michael Moore

Michael Moore自2017年12月起担任VieMed总裁。Moore先生于2006年共同创立了Sleepco子公司,并于2015年5月出售给PHM。在将Sleepco子公司出售给PHM之后,Moore先生成为PHM的总裁,并于2016年3月担任其临时首席财务官。在担任Viemed&8217;s总裁之前,Moore先生于2015年5月至2017年12月担任PHM疾病管理董事总经理。Moore先生在加州健康科学学院(California College of Health Science)完成呼吸治疗师学位后,开始了呼吸治疗师的职业生涯,后来过渡到账户执行官,任职于Praxair和Home Care Supply等组织,在那里,他不断超越销售目标,并在全国所有客户主管中排名前5。


Michael Moore has served as President of the Corporation since December 2017. Mr. Moore co-founded the Sleepco Subsidiaries in 2006 which were sold to PHM in May 2015. After selling the Sleepco Subsidiaries to PHM, Mr. Moore became the President of PHM and in March 2016 its Interim CFO. Prior to serving as the Corporation's President, Mr. Moore acted as Managing Director, Disease Management of PHM from May 2015 until December 2017. After completing his degree as a Respiratory Therapist from the California College of Health Science, Mr. Moore began his career as a Respiratory Therapist and later transitioned to Account Executive, with organizations such as Praxair and Home Care Supply, where he continually exceeded sales goals and finished in the top 5 nationally of all Account Executives.
Michael Moore自2017年12月起担任VieMed总裁。Moore先生于2006年共同创立了Sleepco子公司,并于2015年5月出售给PHM。在将Sleepco子公司出售给PHM之后,Moore先生成为PHM的总裁,并于2016年3月担任其临时首席财务官。在担任Viemed&8217;s总裁之前,Moore先生于2015年5月至2017年12月担任PHM疾病管理董事总经理。Moore先生在加州健康科学学院(California College of Health Science)完成呼吸治疗师学位后,开始了呼吸治疗师的职业生涯,后来过渡到账户执行官,任职于Praxair和Home Care Supply等组织,在那里,他不断超越销售目标,并在全国所有客户主管中排名前5。
Michael Moore has served as President of the Corporation since December 2017. Mr. Moore co-founded the Sleepco Subsidiaries in 2006 which were sold to PHM in May 2015. After selling the Sleepco Subsidiaries to PHM, Mr. Moore became the President of PHM and in March 2016 its Interim CFO. Prior to serving as the Corporation's President, Mr. Moore acted as Managing Director, Disease Management of PHM from May 2015 until December 2017. After completing his degree as a Respiratory Therapist from the California College of Health Science, Mr. Moore began his career as a Respiratory Therapist and later transitioned to Account Executive, with organizations such as Praxair and Home Care Supply, where he continually exceeded sales goals and finished in the top 5 nationally of all Account Executives.
Trae Fitzgerald

Trae Fitzgerald自2017年12月起担任VieMed首席财务官。此前,Fitzgerald先生于2015年1月至2017年12月担任PHM的财务经理兼公司财务总监。在加入PHM之前,Fitzgerald先生于2013年4月至2015年1月在PetroquestEnergy,Inc.(当时的纽交所上市公司)担任了两年的财务,预算和财务报告职务。Fitzgerald先生以优异成绩毕业于路易斯安那大学拉斐特分校(University of Louisiana at Lafayette),获得会计学理学学士学位和工商管理硕士学位。


Trae Fitzgerald has served as the Chief Financial Officer of Corporation since December 2017. Previously, Mr. Fitzgerald served as finance manager and corporate controller of PHM from January 2015 until December 2017. Prior to joining PHM, Mr. Fitzgerald spent two years serving in a finance, budgeting, and financial reporting role for PetroQuest Energy, Inc., a then NYSE listed company, from April 2013 to January 2015. Mr. Fitzgerald graduated Summa Cum Laude with a Bachelor of Science Degree in Accounting and Masters of Business Administration from the University of Louisiana at Lafayette.
Trae Fitzgerald自2017年12月起担任VieMed首席财务官。此前,Fitzgerald先生于2015年1月至2017年12月担任PHM的财务经理兼公司财务总监。在加入PHM之前,Fitzgerald先生于2013年4月至2015年1月在PetroquestEnergy,Inc.(当时的纽交所上市公司)担任了两年的财务,预算和财务报告职务。Fitzgerald先生以优异成绩毕业于路易斯安那大学拉斐特分校(University of Louisiana at Lafayette),获得会计学理学学士学位和工商管理硕士学位。
Trae Fitzgerald has served as the Chief Financial Officer of Corporation since December 2017. Previously, Mr. Fitzgerald served as finance manager and corporate controller of PHM from January 2015 until December 2017. Prior to joining PHM, Mr. Fitzgerald spent two years serving in a finance, budgeting, and financial reporting role for PetroQuest Energy, Inc., a then NYSE listed company, from April 2013 to January 2015. Mr. Fitzgerald graduated Summa Cum Laude with a Bachelor of Science Degree in Accounting and Masters of Business Administration from the University of Louisiana at Lafayette.
Jerome Cambre

Jerome Cambre自2018年3月起担任VieMed的销售Vice President。此前,Cambre先生于2017年3月至2018年3月担任VieMed的全国销售培训师,于2016年3月至2017年3月担任Sleep Management,LLC的临床销售总监,并于2015年10月担任Sleep Management,LLC的患者护理协调员到2016年。在此之前,Cambre先生从2013年11月开始担任Sleep Management,LLC的销售代表。Cambre先生毕业于路易斯安那州立大学(Louisiana State University)心理学理学学士学位。他也持有the Lake College的圣母大学(Our Lady of the Lake College)的心肺科学科学副学士学位。


Jerome Cambre has served as the Vice President of Sales of Corporation since March 2018. Previously, Mr. Cambre served as the National Sales Trainer of the Corporation from March 2017 to March 2018 as the Director of Clinical Sales of Sleep Management, LLC from March 2016 to March 2017 and as a Patient Care Coordinator of Sleep Management, LLC from October 2015 to 2016. Prior to that, Mr. Cambre was a sales representative at Sleep Management, LLC from November 2013. Mr. Cambre graduated with a Bachelor of Science Degree in Psychology from Louisiana State University. He also holds an Associate of Science Degree in Cardiopulmonary Science from Our Lady of the Lake College.
Jerome Cambre自2018年3月起担任VieMed的销售Vice President。此前,Cambre先生于2017年3月至2018年3月担任VieMed的全国销售培训师,于2016年3月至2017年3月担任Sleep Management,LLC的临床销售总监,并于2015年10月担任Sleep Management,LLC的患者护理协调员到2016年。在此之前,Cambre先生从2013年11月开始担任Sleep Management,LLC的销售代表。Cambre先生毕业于路易斯安那州立大学(Louisiana State University)心理学理学学士学位。他也持有the Lake College的圣母大学(Our Lady of the Lake College)的心肺科学科学副学士学位。
Jerome Cambre has served as the Vice President of Sales of Corporation since March 2018. Previously, Mr. Cambre served as the National Sales Trainer of the Corporation from March 2017 to March 2018 as the Director of Clinical Sales of Sleep Management, LLC from March 2016 to March 2017 and as a Patient Care Coordinator of Sleep Management, LLC from October 2015 to 2016. Prior to that, Mr. Cambre was a sales representative at Sleep Management, LLC from November 2013. Mr. Cambre graduated with a Bachelor of Science Degree in Psychology from Louisiana State University. He also holds an Associate of Science Degree in Cardiopulmonary Science from Our Lady of the Lake College.
Patrick Eagan

Patrick Eagan自2020年11月起担任公司总法律顾问。在此之前,他曾于2017年1月至2020年11月担任Ochsner Health System的公司法律顾问,然后担任副总法律顾问,并于2013年7月至2016年12月担任新奥尔良市的助理城市检察官。Eagan先生于2001年毕业于威廉姆斯学院,获得经济学学士学位,并于2006年获得弗吉尼亚大学法学院的法学博士学位。


Patrick Eagan has served as the General Counsel of the Corporation since November 2020. Previously, he served as Corporate Counsel and then as Associate General Counsel of Ochsner Health System from January 2017 to November 2020 and as an Assistant City Attorney of the City of New Orleans from July 2013 to December 2016. Mr. Eagan graduated with a Bachelor of Arts Degree in Economics from Williams College in 2001 and a Juris Doctorate from the University of Virginia School of Law in 2006.
Patrick Eagan自2020年11月起担任公司总法律顾问。在此之前,他曾于2017年1月至2020年11月担任Ochsner Health System的公司法律顾问,然后担任副总法律顾问,并于2013年7月至2016年12月担任新奥尔良市的助理城市检察官。Eagan先生于2001年毕业于威廉姆斯学院,获得经济学学士学位,并于2006年获得弗吉尼亚大学法学院的法学博士学位。
Patrick Eagan has served as the General Counsel of the Corporation since November 2020. Previously, he served as Corporate Counsel and then as Associate General Counsel of Ochsner Health System from January 2017 to November 2020 and as an Assistant City Attorney of the City of New Orleans from July 2013 to December 2016. Mr. Eagan graduated with a Bachelor of Arts Degree in Economics from Williams College in 2001 and a Juris Doctorate from the University of Virginia School of Law in 2006.
W. Todd Zehnder

W. Todd Zehnder,2009年10月起,他担任我公司首席运营官。2008年3月至2009年10月,他担任我公司执行副总裁、首席财务官和会计长;2001年2月至2004年10月,担任我公司财务长;2003年6月至2005年6月,担任我公司营销经理;2004年10月至2005年6月,担任我公司通信董事;2005年6月至2007年5月,担任公司通信副总裁;2005年6月至2008年3月,担任石油天然气营销副总裁;2007年5月至2008年3月,担任公司发展副总裁。2001年2月加入我公司之前,他在毕马威会计师事务所(KPMG LLP)工作5年,负责石油天然气业,达到经理职位。1996年,他在路易斯安那州立大学(Louisiana State University)获得理学士学位,是美国独立石油协会(Independent Petroleum Association of America)、路易斯安那石油天然气协会(Louisiana Oil & Gas Association)和美国注册会计师协会(American Institute of Certified Public Accountants)的成员。


W. Todd Zehnder has served as the Chief Operating Officer and as a director of the Corporation since December 2017. Previously, Mr. Zehnder served as Vice President - Finance and as Chief Strategy Officer of PHM from December 2015 to December 2017. Prior to joining PHM, Mr. Zehnder worked for PetroQuest Energy Inc., which was then a NYSE listed company, for 15 years in various leadership positions, including as Chief Operating Officer and Chief Financial Officer from 2008 to December 2015. Mr. Zehnder began his career with KPMG LLP where he attained the level of Manager. Mr. Zehnder received his Bachelor of Science degree in Accounting from Louisiana State University and is a Certified Public Accountant.
W. Todd Zehnder,2009年10月起,他担任我公司首席运营官。2008年3月至2009年10月,他担任我公司执行副总裁、首席财务官和会计长;2001年2月至2004年10月,担任我公司财务长;2003年6月至2005年6月,担任我公司营销经理;2004年10月至2005年6月,担任我公司通信董事;2005年6月至2007年5月,担任公司通信副总裁;2005年6月至2008年3月,担任石油天然气营销副总裁;2007年5月至2008年3月,担任公司发展副总裁。2001年2月加入我公司之前,他在毕马威会计师事务所(KPMG LLP)工作5年,负责石油天然气业,达到经理职位。1996年,他在路易斯安那州立大学(Louisiana State University)获得理学士学位,是美国独立石油协会(Independent Petroleum Association of America)、路易斯安那石油天然气协会(Louisiana Oil & Gas Association)和美国注册会计师协会(American Institute of Certified Public Accountants)的成员。
W. Todd Zehnder has served as the Chief Operating Officer and as a director of the Corporation since December 2017. Previously, Mr. Zehnder served as Vice President - Finance and as Chief Strategy Officer of PHM from December 2015 to December 2017. Prior to joining PHM, Mr. Zehnder worked for PetroQuest Energy Inc., which was then a NYSE listed company, for 15 years in various leadership positions, including as Chief Operating Officer and Chief Financial Officer from 2008 to December 2015. Mr. Zehnder began his career with KPMG LLP where he attained the level of Manager. Mr. Zehnder received his Bachelor of Science degree in Accounting from Louisiana State University and is a Certified Public Accountant.